News Conference News NY Valves 2025 No Benefit of Sentinel Device During TAVI: Updated Meta-analysis Todd Neale July 04, 2025
News Features Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR Todd Neale October 17, 2022
Presentation TCT 2022 TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device Presenter: Sayonara Daal September 19, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Conference News TCT 2020 Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains Todd Neale October 16, 2020
News Conference News TCT 2020 Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II Todd Neale October 15, 2020
Presentation TCT 2019 TriGUARD 3 Technology and Preliminary Clinical Results Presenter: Jeffrey Moses September 27, 2019
Presentation TVT 2019 Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial Presenter: Tamim Nazif June 13, 2019
Presentation TCT 2018 Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial Presenter: Tamim Nazif September 21, 2018
News Conference News EuroPCR 2018 Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted Caitlin E. Cox May 23, 2018
Presentation TCT 2017 TRIGUARD Design Features and Clinical Findings From EU Clinical Trials Presenter: Joachim Schofer October 31, 2017
Presentation TCT 2017 Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3 Presenter: Francesco Saia, Gerhard C. Schuler, Pieter R. Stella October 31, 2017
News Industry News Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures August 01, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News EuroPCR 2017 Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis Michael O'Riordan May 26, 2017
News Daily News Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way Shelley Wood September 29, 2016
News Daily News La Cognición Post-TAVR Mejora en Algunos Pacientes y Desciende en Otros y son Pocas las Señales Orientativas Shelley Wood September 29, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016